{"transactions":[{"id":4639103,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":156,"exercise_date":"2022-11-17","expiration_date":"2032-11-16","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4639102,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":247.2,"exercise_date":"2021-09-23","expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":121},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4639101,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":63,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":472.8,"exercise_date":"2020-09-16","expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":63},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4639100,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":56,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":422.4,"exercise_date":"2020-06-18","expiration_date":"2029-07-07","underlying":"Common Stock","underlying_shares":56},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4639099,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":232.8,"exercise_date":"2019-09-06","expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4639098,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T14:08:48.000Z","date":"2026-10-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 12, 2026, the Reporting Person voluntarily surrendered stock options exercisable for an aggregate of 566 shares of Common Stock with exercise prices set forth in the table above to the Issuer for cancellation for no consideration. The cancellation is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e) and Rule 16b-6(d), and exempt from the reporting requirements of Section 16(a) pursuant to Rule 16a-4(d). The Reporting Person is voluntarily reporting this transaction."}],"balance_after":0,"derivative":{"exercise_price":208.8,"exercise_date":"2019-07-08","expiration_date":"2029-07-07","underlying":"Common Stock","underlying_shares":6},"source":{"system":"sec-edgar","filing":"0001781026-26-000004","document":"form4-10132026_021044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000004/form4-10132026_021044.xml","form_type":"4"}},{"id":4622866,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T20:11:38.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 17, 2026, March 17, 2027, June 17, 2027 and September 17, 2027."}],"balance_after":78947,"derivative":{"exercise_price":0.38,"expiration_date":"2036-09-16","underlying":"Common Stock","underlying_shares":78947},"source":{"system":"sec-edgar","filing":"0001781026-26-000002","document":"form4-09182026_080934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781026/000178102626000002/form4-09182026_080934.xml","form_type":"4"}},{"id":749462,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:15.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257903/ownership.xml","form_type":"4"}},{"id":938274,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T21:15:32.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":520021,"source":{"system":"sec-edgar","filing":"0001493152-26-002427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002427/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":939035,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T01:51:30.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":520021,"source":{"system":"sec-edgar","filing":"0001493152-26-002297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002297/ownership.xml","form_type":"4"}},{"id":956967,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T21:30:28.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":518774,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029615/ownership.xml","form_type":"4"}},{"id":956966,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T21:30:28.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":490021,"source":{"system":"sec-edgar","filing":"0001493152-25-029615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029615/ownership.xml","form_type":"4"}},{"id":960592,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T21:30:32.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested and became exercisable on December 19, 2025."}],"balance_after":365021,"source":{"system":"sec-edgar","filing":"0001493152-25-028787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225028787/ownership.xml","form_type":"4"}},{"id":990981,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T21:17:38.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":61539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":365021,"source":{"system":"sec-edgar","filing":"0001493152-25-024634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225024634/ownership.xml","form_type":"4"}},{"id":1105613,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:25:44.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":17647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of September 20, 2025, December 20, 2025, March 20, 2026 and June 20, 2026."}],"balance_after":17647,"derivative":{"exercise_price":1.7,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":17647},"source":{"system":"sec-edgar","filing":"0001415889-25-017855","document":"form4-06202025_080640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000141588925017855/form4-06202025_080640.xml","form_type":"4"}},{"id":1119472,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083040/ownership.xml","form_type":"4"}},{"id":1307456,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T21:05:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":362524,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-001221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001221/ownership.xml","form_type":"4"}},{"id":1307455,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-07T21:05:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":303482,"source":{"system":"sec-edgar","filing":"0001493152-25-001221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001221/ownership.xml","form_type":"4"}},{"id":1333158,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T22:37:47.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":8646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."}],"balance_after":8646,"derivative":{"exercise_price":3.47,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":8646},"source":{"system":"sec-edgar","filing":"0001415889-24-029351","document":"form4-12132024_101244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000141588924029351/form4-12132024_101244.xml","form_type":"4"}},{"id":1486606,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-06-07T20:30:07.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":21.79,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000950170-24-070700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024070700/ownership.xml","form_type":"4"}},{"id":1710315,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T21:10:19.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":38136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."}],"balance_after":38136,"derivative":{"exercise_price":0.59,"expiration_date":"2033-12-14","underlying":"Common Stock","underlying_shares":38136},"source":{"system":"sec-edgar","filing":"0001415889-23-016528","document":"form4-12152023_041208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000141588923016528/form4-12152023_041208.xml","form_type":"4"}},{"id":1844654,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T16:05:38.000Z","date":"2023-06-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."}],"balance_after":0,"derivative":{"exercise_price":4.08,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-23-016483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924323016483/doc4.xml","form_type":"4"}},{"id":1844653,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T16:05:38.000Z","date":"2023-06-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."}],"balance_after":0,"derivative":{"exercise_price":4.49,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-23-016483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924323016483/doc4.xml","form_type":"4"}},{"id":1844652,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T16:05:38.000Z","date":"2023-06-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 10, 2023, by and among the Issuer, Swedish Orphan Biovitrum AB (publ) (\"Parent\"), and Cleopatra Acquisition Corp., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of June 26, 2023 (the \"Effective Time\"), each option to purchase shares of Company Common Stock that was outstanding immediately prior to the Effective Time, whether or not vested, with an exercise price that was less than the Offer Price, terminated and was cancelled immediately prior to the Effective Time and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from Footnote 1) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option."}],"balance_after":0,"derivative":{"exercise_price":2.74,"underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-23-016483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924323016483/doc4.xml","form_type":"4"}},{"id":1851231,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-17T01:04:57.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":277778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":277778,"derivative":{"exercise_price":0.7503,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":277778},"source":{"system":"sec-edgar","filing":"0000899243-23-015882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924323015882/doc4.xml","form_type":"4"}},{"id":1851230,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-17T01:04:57.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":199921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 199,921 RSUs granted under the. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":236066,"source":{"system":"sec-edgar","filing":"0000899243-23-015882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924323015882/doc4.xml","form_type":"4"}},{"id":1869497,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-06-02T20:57:50.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":13.32,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-033871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033871/doc4.xml","form_type":"4"}},{"id":1923266,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T18:20:55.000Z","date":"2023-04-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2024 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event."}],"balance_after":80000,"derivative":{"exercise_price":4.08,"expiration_date":"2033-04-05","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-23-010982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924323010982/doc4.xml","form_type":"4"}},{"id":2109361,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-21T21:31:24.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":46154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of  February 17, 2023, May 17, 2023, August 17, 2023 and November 17, 2023."}],"balance_after":112504,"derivative":{"exercise_price":0.65,"expiration_date":"2032-11-16","underlying":"Common Stock","underlying_shares":46154},"source":{"system":"sec-edgar","filing":"0001415889-22-011630","document":"form4-11212022_091115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000141588922011630/form4-11212022_091115.xml","form_type":"4"}},{"id":2206741,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-16T00:52:33.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":54152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":54152,"derivative":{"exercise_price":4.15,"expiration_date":"2032-07-13","underlying":"Class A Common Stock","underlying_shares":54152},"source":{"system":"sec-edgar","filing":"0000899243-22-026193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322026193/doc4.xml","form_type":"4"}},{"id":2206740,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-07-16T00:52:33.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":36145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":36145,"source":{"system":"sec-edgar","filing":"0000899243-22-026193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322026193/doc4.xml","form_type":"4"}},{"id":2222965,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2022-06-23T20:52:02.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":14.84,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-038931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122038931/doc4.xml","form_type":"4"}},{"id":2243595,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-04T01:22:42.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":42413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in three successive equal annual installments so that the option is vested in full on the three-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":42413,"derivative":{"exercise_price":10.37,"expiration_date":"2032-06-02","underlying":"Class A Common Stock","underlying_shares":42413},"source":{"system":"sec-edgar","filing":"0000899243-22-021123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322021123/doc4.xml","form_type":"4"}},{"id":2338462,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T19:46:14.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2023 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event."}],"balance_after":80000,"derivative":{"exercise_price":4.49,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-22-010779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924322010779/doc4.xml","form_type":"4"}},{"id":2560471,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-24T20:02:22.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":29126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option vests ratably on each of December 23, 2021, March 23, 2022, June 23, 2022 and September 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 23, 2021, March 23, 2022, June 23, 2022 and September 23, 2022."}],"balance_after":29126,"derivative":{"exercise_price":1.03,"expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":29126},"source":{"system":"sec-edgar","filing":"0001104659-21-119283","document":"tm2128426-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000110465921119283/tm2128426-1_4seq1.xml","form_type":"4"}},{"id":2657005,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-06-23T21:21:03.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":21.54,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-21-042790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121042790/doc4.xml","form_type":"4"}},{"id":3027395,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-18T20:35:24.000Z","date":"2020-09-16","kind":"grant","acquired":true,"shares":15228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option vests ratably on each of December 16, 2020, March 16, 2021, June 16, 2021 and September 16, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 16, 2020, March 16, 2021, June 16, 2021 and September 16, 2021."}],"balance_after":15228,"derivative":{"exercise_price":1.97,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":15228},"source":{"system":"sec-edgar","filing":"0001213900-20-027372","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390020027372/ownership.xml","form_type":"4"}},{"id":3098417,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-26T20:11:25.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":17.97,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-20-039076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120039076/doc4.xml","form_type":"4"}},{"id":3104811,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:30:13.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13500,"derivative":{"exercise_price":1.76,"exercise_date":"2020-06-18","expiration_date":"2029-07-07","underlying":"COMMON STOCK","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001213900-20-015362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390020015362/ownership.xml","form_type":"4"}},{"id":3392927,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2019-10-16T20:07:15.000Z","date":"2019-10-14","kind":"grant","acquired":true,"shares":8666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":8666,"derivative":{"exercise_price":13.78,"expiration_date":"2029-10-13","underlying":"Common Stock","underlying_shares":8666},"source":{"system":"sec-edgar","filing":"0001209191-19-053278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919119053278/doc4.xml","form_type":"4"}},{"id":3392926,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2019-10-16T20:07:15.000Z","date":"2019-10-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments commencing on the one year anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":13.78,"expiration_date":"2029-10-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-053278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919119053278/doc4.xml","form_type":"4"}},{"id":3408475,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T23:15:19.000Z","date":"2019-09-23","kind":"purchase","acquired":true,"shares":14940,"price":0.9284,"value":13870.296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.9273 to $0.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14940,"source":{"system":"sec-edgar","filing":"0001213900-19-018706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390019018706/ownership.xml","form_type":"4"}},{"id":3418979,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-10T22:38:33.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":30928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option vests ratably on each of December 6, 2019, March 6, 2020, June 6, 2020 and September 6, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 6, 2019, March 6, 2020, June 6, 2020 and September 6, 2020."}],"balance_after":30928,"derivative":{"exercise_price":0.97,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":30928},"source":{"system":"sec-edgar","filing":"0001213900-19-017652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390019017652/ownership.xml","form_type":"4"}},{"id":3466597,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-08T23:51:18.000Z","date":"2019-07-08","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1500,"derivative":{"exercise_price":0.865,"exercise_date":"2019-07-08","expiration_date":"2029-07-07","underlying":"COMMON STOCK","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001213900-19-012261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390019012261/ownership.xml","form_type":"4"}}]}